1. Home
  2. OSK vs CORT Comparison

OSK vs CORT Comparison

Compare OSK & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oshkosh Corporation

OSK

Oshkosh Corporation

N/A

Current Price

$156.84

Market Cap

11.0B

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$33.69

Market Cap

3.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OSK
CORT
Founded
1917
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
3.7B
IPO Year
2009
2001

Fundamental Metrics

Financial Performance
Metric
OSK
CORT
Price
$156.84
$33.69
Analyst Decision
Buy
Buy
Analyst Count
14
6
Target Price
$165.64
$105.20
AVG Volume (30 Days)
690.9K
1.7M
Earning Date
04-29-2026
05-25-2026
Dividend Yield
1.48%
N/A
EPS Growth
N/A
N/A
EPS
1.14
0.82
Revenue
$7,705,500,000.00
$761,407,000.00
Revenue This Year
$6.18
$29.97
Revenue Next Year
$6.56
$30.25
P/E Ratio
$135.85
$41.48
Revenue Growth
12.83
12.79
52 Week Low
$76.82
$28.66
52 Week High
$180.49
$117.33

Technical Indicators

Market Signals
Indicator
OSK
CORT
Relative Strength Index (RSI) 42.03 33.24
Support Level $123.32 $33.53
Resistance Level $158.53 $41.92
Average True Range (ATR) 6.10 2.42
MACD -3.15 0.23
Stochastic Oscillator 25.30 42.56

Price Performance

Historical Comparison
OSK
CORT

About OSK Oshkosh Corporation

Oshkosh is a leading maker of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, including postal, firefighting, refuse/recycling collection, aviation, and construction. It is typically the market share leader or No. 2 player in North America, or even the global leader in the case of its JLG aerial work platform business. The transport segment is a leading provider of light trucks to the military and vehicles to the Postal Service. The vocational segment, featuring brands such as Pierce, AeroTech, and Volterra, offers purpose-built vehicles and equipment to municipalities. The company reports three segments—Access equipment (45% of revenue), Vocational (35%), and Transport (20%) on 2025 revenue of $10.4 billion.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: